Peter Chiba
Impact in
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Metal complexes synthesis and properties
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
- Oncology 72
- Drug Transport and Resistance Mechanisms 67
- Metal complexes synthesis and properties 9
-
- Cancer therapeutics and mechanisms 20
- Biochemical and Molecular Research 16
- Co-authors
- Gerhard F. Ecker (55 shared papers)Stephan Kopp (18 shared papers)Diethart Schmid (15 shared papers)Thomas Stockner (14 shared papers)Manuela Hitzler (12 shared papers)Karin Pleban (6 shared papers)Ishrat Jabeen (5 shared papers)Freya Klepsch (4 shared papers)
- Journals
- Molecular Pharmacology (9 papers)Journal of Medicinal Chemistry (6 papers)Archiv der Pharmazie (6 papers)Advances in experimental medicine and biology (4 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (3 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Peter Chiba
127 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 129
- Oncology 1.7k
- Infectious Diseases 547
- Pharmacology 223
- Physiology 110
- Toxicology 72
Countries citing papers authored by Peter Chiba
This map shows the geographic impact of Peter Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Chiba more than expected).
Fields of papers citing papers by Peter Chiba
This network shows the impact of papers produced by Peter Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Chiba. The network helps show where Peter Chiba may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Chiba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 114 | |
| 2 | 1999 | 110 | |
| 3 | 2004 | 104 | |
| 4 | 2009 | 97 | |
| 5 | 2012 | 96 | |
| 6 | 2007 | 90 | |
| 7 | 2007 | 87 | |
| 8 | 1996 | 83 | |
| 9 | 2011 | 79 | |
| 10 | 2006 | 74 | |
| 11 | 2012 | 74 | |
| 12 | 2004 | 71 | |
| 13 | 1998 | 70 | |
| 14 | 1999 | 68 | |
| 15 | 1990 | 68 | |
| 16 | 2011 | 66 | |
| 17 | 1999 | 62 | |
| 18 | 2009 | 62 | |
| 19 | 1996 | 61 | |
| 20 | 1995 | 58 |
About Peter Chiba
Peter Chiba is a scholar working on Oncology, Molecular Biology, Infectious Diseases, Pediatrics, Perinatology and Child Health and Organic Chemistry, having authored 128 papers that have together received 3.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (67 papers), Cancer therapeutics and mechanisms (20 papers), HIV/AIDS drug development and treatment (18 papers), Biochemical and Molecular Research (16 papers), Pharmacological Effects and Toxicity Studies (13 papers), Computational Drug Discovery Methods (11 papers), Adenosine and Purinergic Signaling (9 papers) and Metal complexes synthesis and properties (9 papers). The work is most often cited by research in Oncology (1.7k citations), Infectious Diseases (547 citations), Pharmacology (223 citations), Physiology (110 citations) and Toxicology (72 citations). Peter Chiba has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Gerhard F. Ecker, Stephan Kopp, Diethart Schmid, Thomas Stockner, Manuela Hitzler, Karin Pleban, Ishrat Jabeen, Freya Klepsch, Tiange Cai and Edina Csaszar. Their work appears in journals such as Molecular Pharmacology, Journal of Medicinal Chemistry, Archiv der Pharmazie, Advances in experimental medicine and biology and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.